Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Laparoscopic Roux-en-Y vs mini-gastric bypass for obesity

Research in the most recent issue of Annals of Surgery shows that laparoscopic mini-gastric bypass is a simpler and safer procedure that has no disadvantage compared with laparoscopic Roux-en-Y gastric bypass.

News image

fiogf49gjkf04

Dr Lee and colleagues conducted a prospective, randomized trial to compare treatments of morbid obesity.

The research team compared the safety and effectiveness of laparoscopic Roux-en-Y gastric bypass and laparoscopic mini-gastric bypass in the treatment of morbid obesity.

Laparoscopic Roux-en-Y gastric bypass has been the gold standard for the treatment of morbid obesity.

Operative morbidity rate was higher in the laparoscopic Roux-en-Y gastric bypass group
Annals of Surgery

While laparoscopic mini-gastric bypass has been reported to be a simple and effective treatment, the team report that data from a randomized trial are lacking.

The researchers recrtuited 80 patients who met the National Institute of Health criteria.

The team randomized 40 patients to receive laparoscopic Roux-en-Y gastric bypass and 40 to laparoscopic mini-gastric bypass.

The research team reported that the minimum postoperative follow-up was 2 years and that perioperative data were assessed.

The researchers determined late complication, excess weight loss, body mass index, quality of life, and comorbidities.

Changes in quality of life were assessed using the Gastro-Intestinal Quality of Life Index.

The researchers found 1 conversion in the laparoscopic Roux-en-Y gastric bypass group.

Operation time was shorter in laparoscopic mini-gastric bypass group and there was no mortality in each group.

The team observed that the operative morbidity rate was higher in the laparoscopic Roux-en-Y gastric bypass group, at 20% versus 8%.

The late complications rate was the same in the 2 groups at 8% with no reoperation.

The team noted that weight loss was 59% and 60% at 1 and 2 years, respectively, in the laparoscopic Roux-en-Y gastric bypass group.

The team noted that percentage weight loss in the group was 65% and 64% in the laparoscopic mini-gastric bypass group.

Residual excess weight of less than 50% at 2 years postoperatively was achieved in 75% of patients in the laparoscopic Roux-en-Y gastric bypass group.

In comparison, the researchers found that residual excess weight loss at 2 years in the laparoscopic mini-gastric bypass group was 95%.

A significant improvement of obesity-related clinical parameters and complete resolution of metabolic syndrome in both groups were noted.

In addition, the researchers observed that gastrointestinal quality of life increased significantly without any significant difference between the groups.

Dr Lee's team concludes, “Both laparoscopic Roux-en-Y gastric bypass and laparoscopic mini-gastric bypass are effective for morbid obesity with similar results for resolution of metabolic syndrome and improvement of quality of life.”

“Laparoscopic mini-gastric bypass is a simpler and safer procedure that has no disadvantage compared with laparoscopic Roux-en-Y gastric bypass at 2 years of follow-up.”

Ann Surg 2005: 242(1): 20-8
30 June 2005

Go to top of page Email this page Email this page to a colleague

 23 November 2017 
Distance travelling for rectal cancer outcomes
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Pharmacological management of GERD
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 21 November 2017 
Prepregnancy obesity and maternal mortality
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us